drugset / Trial / NCT02987985

Efficacy of Opioid-free Anesthesia in Reducing Postoperative Respiratory Depression in Children Undergoing Tonsillectomy

NCT02987985

Phase 3 Completed 50 enrolled University of Saskatchewan
RandomizedParallel-groupTriple-blindPrevention

Summary

The objective of this trial is to determine whether an opioid-free general anesthetic (OFA) technique utilizing ketamine, dexmedetomidine, lidocaine, and gabapentin can help reduce postoperative respiratory depression in the post-anesthesia care unit and ward in children with sleep-disordered breathing undergoing tonsillectomy when compared with traditional opioid-containing techniques. It is expected that this OFA regimen will have a measurable reduction on postoperative respiratory depression in children with sleep-disordered breathing.

Timeline

Start
2017-10-15
Primary completion
2019-09-20
Completion
2020-12-20

Drugs

EvaluationDrugModalityDoseRoute
Comparator Fentanyl Other / unclassified 0.5 ug/kg
Subject Gabapentin Small molecule 10 mg/kg
Subject Ketamine Small molecule 0.5 mg/kg
Subject Lidocaine Other / unclassified 1 mg/kg
Background Acetaminophen Small molecule 15 mg/kg
Background Dexamethasone Small molecule 150 ug/kg
Background Dexmedetomidine Other / unclassified 0.3 ug/kg
Background Ondansetron Other / unclassified 50 mg/kg
Background Sevoflurane Other / unclassified